
Sanara MedTech (SMTI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Sanara MedTech (SMTI) last issued guidance on May 11, 2026 for Q2 2026. The company guided revenue in the range of $28.5M - $29.5M for the period.
Compared to prior guidance, Sanara MedTech lowered its revenue forecast from a prior range of $116M - $121M.
Sanara MedTech has issued 12 guidance updates between February 22, 2023 and May 11, 2026. During this period, the company raised its outlook 5 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.05 | $-0.18 | $0.11 | $-0.23 |
| Actual | $-0.05 | $0.05 | $0.09 | $0.09 |
| Surprise | 0.00% | +127.8% | -18.2% | +139.1% |
| Revenue | ||||
| Estimate | $29.0M | $26.8M | $27.4M | $26.6M |
| Actual | $28.1M | $27.8M | $27.5M | $26.3M |
| Surprise | -3.11% | +3.65% | +0.53% | -1.13% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.03 | $0.17 |
| Revenue | ||
| Consensus | $29.7M | $31.3M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.05 | $-0.05 | 0.00 % |
| Q1 | May 11, 2026 | $0.05 | $-0.18 | 127.8 % |
| Q4 | Mar 24, 2026 | $0.09 | $0.11 | -18.2 % |
| Q3 | Nov 12, 2025 | $0.09 | $-0.23 | 139.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $28.14M | $29.04M | -3.11 % |
| Q1 | May 11, 2026 | $27.80M | $26.82M | 3.65 % |
| Q4 | Mar 24, 2026 | $27.55M | $27.40M | 0.53 % |
| Q3 | Nov 12, 2025 | $26.33M | $26.64M | -1.13 % |